DEF 14A: Regional Health Properties Sets Date for 2024 Annual Shareholder Meeting

Regional Health Properties has announced its 2024 Annual Meeting of Shareholders to be held on January 14, 2025, to vote on the election of directors and the ratification of the company's independent auditor.

Summary

• Regional Health Properties, Inc. will hold its 2024 Annual Meeting of Shareholders on Tuesday, January 14, 2025, at 10:00 a.m. local time in Atlanta, Georgia.
• Shareholders will vote on the election of four director nominees, with three directors to be elected by common stock holders and one by Series B Preferred Stock holders.
• The meeting will also include a vote to ratify the appointment of Cherry Bekaert, LLP as the company's independent registered public accounting firm for the year ending December 31, 2024.
• The record date for determining shareholders eligible to vote is December 2, 2024.
• Proxy materials were first mailed to shareholders on or about December 16, 2024.
• A quorum for the meeting requires the presence, in person or by proxy, of one-third of the votes entitled to be cast on a matter.
• As of the record date, there were 1,879,249 shares of common stock and 2,252,272 shares of Series B Preferred Stock outstanding.

Sentiment

Score: 7

Explanation: The document is a routine proxy statement, with no significant positive or negative surprises. The sentiment is neutral to slightly positive due to the standard corporate governance practices and the board's recommendations.

Positives

• The company is providing shareholders with multiple ways to vote, including via the internet and mail.
• The board is recommending shareholders vote for all director nominees and the ratification of the independent auditor.
• The company has a Lead Independent Director to enhance the board's independence from management.
• The board has determined that three of the four director nominees are independent.
• The company has a code of ethics and a clawback policy in place.

Negatives

• The company's Series A Preferred Stock holders are not entitled to vote at the Annual Meeting.
• The company does not provide any retirement plans or programs.
• One director made a late filing reporting the grant of one equity award and another director made a late filing reporting initial ownership.

Risks

• If a quorum is not present, the meeting may be adjourned.
• If shareholders do not ratify the appointment of Cherry Bekaert, the Audit Committee will evaluate whether to select a different independent auditor.
• There is a risk that a director nominee may be unable to stand for election, requiring the board to designate a substitute nominee.
• The company's financial performance is not discussed in detail in this document, which is a risk for investors.

Future Outlook

The document does not contain specific forward-looking statements about the company's future financial performance or strategic direction, but it does outline the procedures for shareholders to submit proposals for the 2025 annual meeting.

Management Comments

• Brent S. Morrison, Chief Executive Officer, President, Corporate Secretary and Chairman of the Board, invites shareholders to attend the 2024 Annual Meeting.
• The Board recommends that shareholders vote FOR the election of the four director nominees and FOR the ratification of the appointment of Cherry Bekaert as the independent auditor.

Industry Context

This document is a standard proxy statement for a publicly traded company, outlining the procedures for an annual shareholder meeting. It does not provide specific information about the company's performance relative to its industry or competitors.

Comparison to Industry Standards

• The director compensation structure is typical for a company of this size, with a mix of cash retainers and meeting fees.
• The use of a Lead Independent Director is a common practice to enhance corporate governance.
• The company's approach to risk oversight, with the board and its committees involved, is consistent with industry best practices.
• The company's clawback policy is in line with the Dodd-Frank Act requirements.
• The company's equity compensation plan is a standard method for incentivizing employees and directors.

Management Changes

Related Party Transactions

• Mr. Martin is affiliated with holders of the company's Series B Preferred Stock and was nominated by them.
• Mr. Morrison owns bonds secured by the Eaglewood Village facility.

Stakeholder Impact

• Shareholders will have the opportunity to vote on key matters at the annual meeting.
• Employees are subject to the company's code of ethics and insider trading policy.
• The company's financial performance and governance practices impact all stakeholders.

Next Steps

• Shareholders are encouraged to vote on the proposals before the January 13, 2025 deadline.
• The company will hold its 2024 Annual Meeting of Shareholders on January 14, 2025.
• The company will prepare for the 2025 Annual Meeting, including receiving shareholder proposals and director nominations.

Key Dates

Keywords

Annual Meeting, Shareholders, Proxy Statement, Board of Directors, Director Election, Independent Auditor, Cherry Bekaert, Corporate Governance, Executive Compensation, Voting Rights